WALTHAM, Mass., Sept. 28, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious ...
Filmed at the birthplace of Silicon Valley, this longform conversation dives into the remarkable journey of scientist and entrepreneur Tim Springer.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results